tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Psychedelic: Clearmind completes clinical site initiations for AUD trial
The FlyPsychedelic: Clearmind completes clinical site initiations for AUD trial
3d ago
CMND
CMPS
Cybin Expands Strategic Partnerships for Phase 3 MDD Treatment Trials
PremiumCompany Announcements
Cybin Expands Strategic Partnerships for Phase 3 MDD Treatment Trials
4d ago
CYBN
Cybin announces additional CYB003 strategic partnership agreements
PremiumThe Fly
Cybin announces additional CYB003 strategic partnership agreements
4d ago
CYBN
Cybin Partners with Osmind to Boost Commercial Readiness for Psychiatry Programs
PremiumCompany Announcements
Cybin Partners with Osmind to Boost Commercial Readiness for Psychiatry Programs
6d ago
CYBN
Psychedelic: Exclusive talk with retreat provider ONE Retreats
PremiumThe Fly
Psychedelic: Exclusive talk with retreat provider ONE Retreats
1M ago
ATAI
CMND
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
PremiumThe FlyPsychedelic: Exclusive talk with biotech company Clearmind Medicine
1M ago
ATAI
CMND
Psychedelic: atai Life Sciences, NRx report quarterly results
Premium
The Fly
Psychedelic: atai Life Sciences, NRx report quarterly results
1M ago
ATAI
CMND
Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial
Premium
The Fly
Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial
2M ago
ATAI
CMND
Cybin initiated with a Buy at Guggenheim
PremiumThe Fly
Cybin initiated with a Buy at Guggenheim
2M ago
CYBN
Cybin initiated with a Buy at Guggenheim
PremiumThe Fly
Cybin initiated with a Buy at Guggenheim
2M ago
CYBN
Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress
PremiumCompany Announcements
Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress
2M ago
CYBN
Psychedelic: MindMed reports Q4 earnings results
PremiumThe Fly
Psychedelic: MindMed reports Q4 earnings results
2M ago
ATAI
CMND
Psychedelic: GH Research, Compass Pathways report earnings results
PremiumThe FlyPsychedelic: GH Research, Compass Pathways report earnings results
2M ago
ATAI
CMND
Psychedelic: Exclusive talk with biotech company Enveric Biosciences
Premium
The Fly
Psychedelic: Exclusive talk with biotech company Enveric Biosciences
2M ago
ATAI
CMND
Cybin price target lowered to $150 from $190 at H.C. Wainwright
Premium
The Fly
Cybin price target lowered to $150 from $190 at H.C. Wainwright
2M ago
CYBN
Cybin price target lowered to $73 from $86 at Canaccord
PremiumThe Fly
Cybin price target lowered to $73 from $86 at Canaccord
2M ago
CYBN
Cybin Accelerates PARADIGM Program for Depression Treatment
PremiumCompany Announcements
Cybin Accelerates PARADIGM Program for Depression Treatment
3M ago
CYBN
Psychedelic: Relmada acquires neurosteroid from Asarina
PremiumThe Fly
Psychedelic: Relmada acquires neurosteroid from Asarina
3M ago
ATAI
CMND
Psychedelic: atai Life Sciences reports BPL-003 study results
PremiumThe Fly
Psychedelic: atai Life Sciences reports BPL-003 study results
3M ago
ATAI
CMND
Cybin’s depression program advancing in Phase 3, says H.C. Wainwright
PremiumThe FlyCybin’s depression program advancing in Phase 3, says H.C. Wainwright
3M ago
CYBN
Cybin Partners with Segal Trials for Pivotal Phase 3 Program
Premium
Company Announcements
Cybin Partners with Segal Trials for Pivotal Phase 3 Program
3M ago
CYBN
Cybin launches clinical site partnerships to support PARADIGM program
Premium
The Fly
Cybin launches clinical site partnerships to support PARADIGM program
3M ago
CYBN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >